These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2903234)

  • 1. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
    Gold LH; Koob GF; Geyer MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
    Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
    Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.
    Paulus MP; Geyer MA
    Neuropsychopharmacology; 1992 Aug; 7(1):15-31. PubMed ID: 1355968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
    Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA
    Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
    Hiramatsu M; Nabeshima T; Kameyama T; Maeda Y; Cho AK
    Pharmacol Biochem Behav; 1989 Jun; 33(2):343-7. PubMed ID: 2573077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH; Hubner CB; Koob GF
    Psychopharmacology (Berl); 1989; 99(1):40-7. PubMed ID: 2571175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    Callaway CW; Geyer MA
    Eur J Pharmacol; 1992 Apr; 214(1):45-51. PubMed ID: 1349861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine.
    Hegadoren KM; Martin-Iverson MT; Baker GB
    Psychopharmacology (Berl); 1995 Apr; 118(3):295-304. PubMed ID: 7617822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; "EVE").
    Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1987 Oct; 28(2):153-6. PubMed ID: 2891144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ; Levin JA; Lovenberg W
    Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW; Rempel N; Peng RY; Geyer MA
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):645-8. PubMed ID: 2896363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.